Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B
Clinical trial NCT01687608 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01687608
- Sponsor
- Baxalta now part of Shire
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-11
- Primary completion
- 2030-01-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.